A descriptive study of racial inequalities in mortality from hepatocellular cancer before and after licensure of lifesaving drugs for hepatitis C virus in the United States

Author:

Levine Robert S,Mejia Maria C,Salemi Jason L,Gonzalez Sandra J,Aliyu Muktar H,Husaini Baqar A,Zoorob Roger J,Hennekens Charles H

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Liver cancer. Chapter 33 in thun MJ, (Lead editor), linet MS, cerhan JR, haiman CD and schottenfeld D (Co-Editors) and landgren am (Project manager);London,2018

2. Epidemiology of hepatocellular carcinoma;Lafaro;Surg Oncol Clin N Am,2015

3. Annual report to the nation on the status of cancer, 1975–2012;Ryerson;Featur Increas Incidence Liver Cancer,2016

4. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States;Altekruse;Am J Gastroenterol,2014

5. Hepatitis Central. Medications to treat hepatitis c – a timeline. Available at URL: https://www.hepatitiscentral.com/medications-to-treat-hepatitis-c-a-timeline/Accessed May 26, 2019 and March 22, 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3